NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
Arora R, Haynes L, Kumar M, McNeil R, Ashkani J, Nakoneshny SC, Matthews TW, Chandarana S, Hart RD, Jones SJM, Dort JC, Itani D, Chanda A, Bose P.
Arora R, et al. Among authors: chanda a.
Cancer Gene Ther. 2023 May;30(5):752-765. doi: 10.1038/s41417-022-00578-8. Epub 2023 Jan 12.
Cancer Gene Ther. 2023.
PMID: 36635327
Free PMC article.